(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
These HGTV stars made a pledge to keep their kids off smartphones. Here's how it's going.31.12.2025 - 2The most effective method to Recognize an Excellent Lab Precious stone17.10.2023
- 3Exclusive-Head of Pemex's production arm to step down in coming days, sources say18.12.2025
- 4Surging measles cases are 'fire alarm' warning that other diseases could be next28.11.2025
- 5Chicago reports first rabies-positive dog in 61 years. What we know.24.12.2025
- Manual for Picking Coastline Travel
- Iran Used $2 Billion in Crypto to Run Its Militant Proxies in 2025
- The most effective method to Use an Internet Showcasing Degree for Advanced Predominance
- Father and son spending Christmas together after health scares
- Moon fever hits DC as Artemis 2 rocket 'candle' lights up Washington Monument just 1 month before launch (photos)
- How to watch the last supermoon of the year
- Gauging the Upsides and downsides of Visas: A Complete Aide
- Picking the Right Air Purifier for Your Home
- The Tradition of Stone: A Gander at Notable Structures Through the Ages
